Nuclear Medicine

Nuclear medicine (also called molecular imaging) includes positron emission computed tomography (PET) and single photon emission computed tomography (SPECT) imaging. Nuclear imaging is achieved by injecting small amounts of radioactive material (radiopharmaceuticals) into patients before or during their scan. These can use sugars or chemical traits to bond to specific cells. The radioactive material is taken up by cells that consume the sugars. The radiation emitted from inside the body is detected by photon detectors outside the body. Computers take the data to assemble images of the radiation emissions. Nuclear images may appear fuzzy or ghostly rather than the sharper resolution from MRI and CT.  But, it provides metabolic information at a cellular level, showing if there are defects in the function of the heart, areas of very high metabolic activity associated with cancer cells, or areas of inflammation, data not available from other modalities. These noninvasive imaging exams are used to diagnose cancer, heart disease, Alzheimer’s and Parkinson’s disease, bone disorders and other disorders. 

E-cigarettes cause worse inflammation than tobacco cigarettes, new PET data shows

The use of e-cigarettes has increased significantly in recent years, mostly due to the fact that many consumers believe them to be a safer option than traditional cigarettes.

January 25, 2023
new radiotracer studies inflammation

New radiotracer could change how radiologists understand inflammation

Labeled as LW223, the fluorinated PET radiotracer is the first of its kind to be impervious to rs6971 polymorphism—a genetic mutation that inhibits the diagnostic view of inflammation imaging.

January 24, 2023

A 'clear lack of adherence' in imaging guidelines is impacting lung cancer survival rates

A study published in the January issue of the Journal of Nuclear Medicine reveals that nearly half of Medicare patients with NSCLC in the United States do not complete recommended FDG PET/CT scans prior to treatment.

January 19, 2023
Blood pressure

‘Revolutionary’ new CT scans identify the most common cause of high blood pressure

Primary aldosteronism (PA) is one the single most common causes of hypertension, but identifying patients with PA—and knowing which ones may benefit from a surgical treatment—can be quite challenging.

January 17, 2023
Blood pressure

New type of PET/CT scan could change how hypertension is diagnosed and treated

The 10-minute scan can “light up” aldosterone-producing nodules in the adrenal glands following an injection of metomidate—a radioactive dye that binds specifically to aldosterone-producing nodules.

January 17, 2023
vaccine syringe covid-19 coronavirus

PET radiotracer reduces false positives owed to COVID vaccination

With COVID booster vaccinations expected to continue, the new findings are especially relevant.

January 12, 2023
University of Missouri Research Reactor

Plans for another nuclear facility that can produce medical isotopes in the works

Many of the facilities that produce these critical isotopes are aging, which is a big cause for concern in the future among experts in the field, many of whom believe that the supply chain for radioisotopes is already fragile.

January 12, 2023
cardiac amyloidosis on bone scan

Cardiac amyloidosis becoming less rare thanks to nuclear medicine studies

A new study in the Journal of Nuclear Medicine offers insight into how the condition affects the general population, as well as how radiologists can help in the cardiac amyloidosis diagnostic journey.

January 4, 2023

Around the web

The newly approved AI models are designed to improve the detection of pulmonary embolisms and strokes in patients who undergo CT scans.

"I see, at least for the next decade, this being a SPECT and PET world, not one or the other," explained Tim Bateman, MD.

The FDA-approved technology developed by HeartFlow can predict a patient's long-term risk of target vessel failure as well as more invasive treatments performed inside a cath lab. 

Trimed Popup
Trimed Popup